World

Uzbeks largely approve new constitution

May 02, 2023

Moscow [Russia], May 2: Uzbek citizens approved a new constitution, official figures show, with more than 90% in favour. The head of the electoral commission, ZayniddinNizamkhodjayev, said on Monday that 90.21% had voted for the new constitution, Uza state news agency reported.
The constitutional amendment is widely seen to extend President ShavkatMirziyoyev's term in office. Voter turnout reached 84.54%, according to Nizamkhodjayev, meaning some 16.7 million Uzbek citizens took part in the election. The lower and upper houses of parliament have already passed the new constitution. The new constitution provides for reducing the Senate, the upper house of parliament, from 100 to 65 deputies. Also, it extends the president's term of office from five to seven years. It further abolishes the death penalty.
The president may still only rule for two terms. However, Mirsiyoyev, in office since 2016, can also run in the next election in 2026. Due to the constitutional amendment, his two previous terms in office would no longer count. A similar arrangement has permitted Russian President Vladimir Putin to remain in office, with the procedure carried out in 2021 to allow him to be re-elected, which would otherwise have been unconstitutional.
Source: Qatar Tribune

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024